98 related articles for article (PubMed ID: 22881339)
1. Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura.
Du VX; van Os G; Kremer Hovinga JA; Dienava-Verdoold I; Wollersheim J; Ruggeri ZM; Fijnheer R; de Groot PG; de Laat B
Br J Haematol; 2012 Oct; 159(1):94-103. PubMed ID: 22881339
[TBL] [Abstract][Full Text] [Related]
2. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
3. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.
Mayr FB; Knöbl P; Jilma B; Siller-Matula JM; Wagner PG; Schaub RG; Gilbert JC; Jilma-Stohlawetz P
Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura.
Karpman D; Lethagen S; Kristoffersson A; Isaksson C; Holmberg L
Thromb Haemost; 1997 Dec; 78(6):1456-62. PubMed ID: 9423794
[TBL] [Abstract][Full Text] [Related]
5. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
8. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.
Chow TW; Turner NA; Chintagumpala M; McPherson PD; Nolasco LH; Rice L; Hellums JD; Moake JL
Am J Hematol; 1998 Apr; 57(4):293-302. PubMed ID: 9544973
[TBL] [Abstract][Full Text] [Related]
9. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.
Kumar RA; Moake JL; Nolasco L; Bergeron AL; Sun C; Dong JF; McIntire LV
Biorheology; 2006; 43(5):681-91. PubMed ID: 17047284
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of von Willebrand factor in thrombotic thrombocytopenic purpura.
Lian EC; Siddiqui FA
Blood; 1985 Nov; 66(5):1219-21. PubMed ID: 3876857
[TBL] [Abstract][Full Text] [Related]
11. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
[TBL] [Abstract][Full Text] [Related]
12. beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation.
Hulstein JJ; Lenting PJ; de Laat B; Derksen RH; Fijnheer R; de Groot PG
Blood; 2007 Sep; 110(5):1483-91. PubMed ID: 17488878
[TBL] [Abstract][Full Text] [Related]
13. A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow.
Galbusera M; Remuzzi A; Benigni A; Rossi C; Remuzzi G
Am J Kidney Dis; 2000 Oct; 36(4):695-702. PubMed ID: 11007670
[TBL] [Abstract][Full Text] [Related]
14. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Murphy WG
Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons.
Feys HB; Roodt J; Vandeputte N; Pareyn I; Mottl H; Hou S; Lamprecht S; Van Rensburg WJ; Deckmyn H; Vanhoorelbeke K
Blood; 2012 Oct; 120(17):3611-4. PubMed ID: 22855603
[TBL] [Abstract][Full Text] [Related]
16. Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.
Geys L; Roose E; Scroyen I; Rottensteiner H; Tersteeg C; Hoylaerts MF; Vanhoorelbeke K; Lijnen HR
J Thromb Haemost; 2018 Jan; 16(1):150-163. PubMed ID: 29121438
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare.
Moake JL; Chow TW
Am J Med Sci; 1998 Aug; 316(2):105-19. PubMed ID: 9704664
[TBL] [Abstract][Full Text] [Related]
19. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group].
Tatewaki W
Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]